SYNLOGIC, INC. Line of Credit Facility, Maximum Borrowing Capacity
SYNLOGIC, INC. (SYBX) had Line of Credit Facility, Maximum Borrowing Capacity of $1.00 million as of 2017-07-31, per its 10-K filed 2024-03-19.
Discontinued › Notes
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2024-03-19
- 2017-07-31: Line of Credit Facility, Maximum Borrowing Capacity $1.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2017-07-31 | $1.00M 10-K · filed 2024-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |